Ibrahim Azar
Impact in
-
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
-
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Papers in
- Oncology 14
- Lung Cancer Research Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Diagnosis and Treatment 2
- Cancer-related Molecular Pathways 2
-
- RNA Interference and Gene Delivery 2
- RNA Research and Splicing 2
- Co-authors
- François Coutlée (1 shared paper)Hélène Sénéchal (1 shared paper)Thibault Mésplède (1 shared paper)Jacques Archambault (1 shared paper)David Gagnon (1 shared paper)Syed Mehdi (7 shared papers)Syed Jafar Mehdi (1 shared paper)Misako Nagasaka (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer Research (1 paper)BMC Infectious Diseases (1 paper)Journal of Virology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Ibrahim Azar
23 papers receiving 214 citations
Peers
Comparison fields: 5 of 54
- Oncology 103
- Epidemiology 65
- Cancer Research 21
- Complementary and Manual Therapy 3
- Pathology and Forensic Medicine 19
Countries citing papers authored by Ibrahim Azar
This map shows the geographic impact of Ibrahim Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Azar more than expected).
Fields of papers citing papers by Ibrahim Azar
This network shows the impact of papers produced by Ibrahim Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Azar. The network helps show where Ibrahim Azar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim Azar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 71 | |
| 2 | 2019 | 24 | |
| 3 | 2021 | 22 | |
| 4 | 2022 | 15 | |
| 5 | 2023 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2015 | 11 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 6 | |
| 10 | 2023 | 6 | |
| 11 | 2025 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2016 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2019 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2014 | 2 |
About Ibrahim Azar
Ibrahim Azar is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Economics and Econometrics, having authored 25 papers that have together received 217 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer Diagnosis and Treatment (2 papers), Cancer-related Molecular Pathways (2 papers), Economic and Financial Impacts of Cancer (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Oncology (103 citations), Epidemiology (65 citations), Cancer Research (21 citations), Complementary and Manual Therapy (3 citations) and Pathology and Forensic Medicine (19 citations). Ibrahim Azar has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include François Coutlée, Hélène Sénéchal, Thibault Mésplède, Jacques Archambault, David Gagnon, Syed Mehdi, Syed Jafar Mehdi, Misako Nagasaka, Mohammed Najeeb Al Hallak and Ammar Sukari. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, BMC Infectious Diseases, Journal of Virology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.